Mathé EA, Patterson AD, Haznadar M, Manna SK, Krausz KW, Bowman ED, et al. Noninvasive urinary metabolomic profiling identifies diagnostic and prognostic markers in lung cancer. Cancer Res. 2014;74:3259–70.

Article  PubMed  PubMed Central  Google Scholar 

Haznadar M, Cai Q, Krausz KW, Bowman ED, Margono E, Noro R et al. Urinary metabolite risk biomarkers of lung cancer: A prospective cohort study. Cancer Epidemiol Biomarkers Prev. 2016.

Van Niel G, D’Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol [Internet]. Nature Publishing Group; 2018;19:213–28. Available from: https://doi.org/10.1038/nrm.2017.125.

Shao H, Im H, Castro CM, Breakefield X, Weissleder R, Lee H. New Technologies for analysis of Extracellular vesicles. Chem Rev. 2018;118:1917–50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang H, Freitas D, Kim HS, Fabijanic K, Li Z, Chen H et al. Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation. Nat Cell Biol [Internet]. Springer US; 2018;20:332–43. Available from: https://doi.org/10.1038/s41556-018-0040-4.

Lin J, Wang Y, Zou YQ, Chen X, Huang B, Liu J et al. Differential miRNA expression in pleural effusions derived from extracellular vesicles of patients with lung cancer, pulmonary tuberculosis, or pneumonia. Tumor Biol [Internet]. Tumor Biology; 2016;37:15835–45. Available from: https://doi.org/10.1007/s13277-016-5410-6.

Yuwen D, Ma Y, Wang D, Gao J, Li X, Xue W, et al. Prognostic role of circulating exosomal mir-425-3p for the response of NSCLC to platinum-based chemotherapy. Cancer Epidemiol Biomarkers Prev. 2019;28:163–73.

Article  CAS  PubMed  Google Scholar 

Cui H, Seubert B, Stahl E, Dietz H, Reuning U, Moreno-Leon L et al. Tissue inhibitor of metalloproteinases-1 induces a pro-tumourigenic increase of miR-210 in lung adenocarcinoma cells and their exosomes. Oncogene [Internet]. Oncogene; 2015 [cited 2023 Mar 17];34:3640–50. Available from: https://pubmed.ncbi.nlm.nih.gov/25263437/.

Zhu Q, Huang L, Yang Q, Ao Z, Yang R, Krzesniak J, et al. Metabolomic analysis of exosomal-markers in esophageal squamous cell carcinoma. Nanoscale. 2021;13:16457–64.

Article  CAS  PubMed  Google Scholar 

Li Y, Zhang Y, Qiu F, Qiu Z. Proteomic identification of exosomal LRG1: a potential urinary biomarker for detecting NSCLC. Electrophoresis. 2011;32:1976–83.

Article  CAS  PubMed  Google Scholar 

Sandfeld-Paulsen B, Aggerholm-Pedersen N, Bæk R, Jakobsen KR, Meldgaard P, Folkersen BH et al. Exosomal proteins as prognostic biomarkers in non-small cell lung cancer. Mol Oncol [Internet]. Elsevier B.V; 2016;10:1595. Available from: https://doi.org/10.1016/j.molonc.2016.10.003.

Yang Q, Cheng L, Hu L, Lou D, Zhang T, Li J et al. An integrative microfluidic device for isolation and ultrasensitive detection of lung cancer-specific exosomes from patient urine. Biosens Bioelectron [Internet]. Elsevier B.V.; 2020;163:112290. Available from: https://doi.org/10.1016/j.bios.2020.112290.

Clos-Garcia M, Loizaga-Iriarte A, Zuñiga-Garcia P, Sánchez-Mosquera P, Rosa Cortazar A, González E et al. Metabolic alterations in urine extracellular vesicles are associated to prostate cancer pathogenesis and progression. J Extracell Vesicles [Internet]. Taylor & Francis; 2018;7. Available from: https://doi.org/10.1080/20013078.2018.1470442.

Rodríguez M, Bajo-Santos C, Hessvik NP, Lorenz S, Fromm B, Berge V, et al. Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes. Mol Cancer. 2017;16:4–9.

Article  Google Scholar 

Skotland T, Ekroos K, Kauhanen D, Simolin H, Seierstad T, Berge V et al. Molecular lipid species in urinary exosomes as potential prostate cancer biomarkers. Eur J Cancer [Internet]. Elsevier Ltd; 2017;70:122–32. Available from: https://doi.org/10.1016/j.ejca.2016.10.011.

Lee J, McKinney KQ, Pavlopoulos AJ, Niu M, Kang JW, Oh JW, et al. Altered proteome of extracellular vesicles derived from bladder cancer patients urine. Mol Cells. 2018;41:179–87.

CAS  PubMed  PubMed Central  Google Scholar 

Zhan Y, Du L, Wang L, Jiang X, Zhang S, Li J, et al. Expression signatures of exosomal long non-coding RNAs in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis. Mol Cancer Molecular Cancer. 2018;17:1–5.

Google Scholar 

Dimuccio V, Ranghino A, Barbato LP, Fop F, Biancone L, Camussi G et al. Urinary CD133 + extracellular vesicles are decreased in kidney transplanted patients with slow graft function and vascular damage. PLoS ONE. 2014;9.

Yamamoto CM, Murakami T, Oakes ML, Mitsuhashi M, Kelly C, Henry RR, et al. Uromodulin mRNA from urinary extracellular vesicles correlate to kidney function decline in type 2 diabetes Mellitus. Am J Nephrol. 2018;47:283–91.

Article  CAS  PubMed  Google Scholar 

Zhu Q, Cheng L, Deng C, Huang L, Li J, Wang Y, et al. The genetic source tracking of human urinary exosomes. PNAS. 2021;118:10–2.

Article  Google Scholar 

Erdbrügger U, Blijdorp CJ, Bijnsdorp IV, Borràs FE, Burger D, Bussolati B et al. Urinary extracellular vesicles: A position paper by the Urine Task Force of the International Society for Extracellular Vesicles. J Extracell Vesicles. 2021;10.

Street JM, Koritzinsky EH, Glispie DM, Star RA, Yuen PST. Urine Exosomes: An Emerging Trove of Biomarkers [Internet]. 1st ed. Adv. Clin. Chem. Elsevier Inc.; 2017. Available from: https://doi.org/10.1016/bs.acc.2016.07.003.

Ni J, Mi Y, Wang B, Zhu Y, Ding Y, Ding Y, et al. Naturally equipped urinary exosomes coated poly (2 – ethyl – 2–oxazoline) – poly (D, L – lactide) nanocarriers for the pre – clinical translation of breast Cancer. Bioengineering. 2022;9:363.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nedaeinia R, Manian M, Jazayeri MH, Ranjbar M, Salehi R, Sharifi M, et al. Circulating exosomes and exosomal microRNAs as biomarkers in gastrointestinal cancer. Cancer Gene Ther. 2017;24:48–56.

Article  CAS  PubMed  Google Scholar 

Wu L, Li S, Shu P, Liu Q. Effect of exosomal miRNA on cancer biology and clinical applications. Evidence-based Complement Altern Med Molecular Cancer. 2022;2022:1–19.

Google Scholar 

Liu C, Zhao J, Tian F, Cai L, Zhang W, Feng Q et al. Low-cost thermophoretic profiling of extracellular-vesicle surface proteins for the early detection and classification of cancers. Nat Biomed Eng [Internet]. Springer US; 2019;3:183–93. Available from: https://doi.org/10.1038/s41551-018-0343-6.

Gowda GAN, Zhang S, Gu H, Asiago V, Shanaiah N, Raftery D. Metabolomics-based methods for early disease diagnostics. Expert Rev Mol Diagn. 2008;8:617–33.

Article  CAS  PubMed  Google Scholar 

Chen L, Lu W, Wang L, Xing X, Chen Z, Teng X, et al. Metabolite discovery through global annotation of untargeted metabolomics data. Nat Methods Springer US. 2021;18:1377–85.

Article  Google Scholar 

Yang E, Wang X, Gong Z, Yu M, Wu H, Zhang D. Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression. Signal Transduct Target Ther [Internet]. Springer US; 2020;5:1–13. Available from: https://doi.org/10.1038/s41392-020-00359-5.

Min L, Zhu S, Chen L, Liu X, Wei R, Zhao L et al. Evaluation of circulating small extracellular vesicles derived miRNAs as biomarkers of early colon cancer: a comparison with plasma total miRNAs. J Extracell Vesicles [Internet]. Taylor & Francis; 2019;8. Available from: https://doi.org/10.1080/20013078.2019.1643670.

Lázaro-Ibáñez E, Lunavat TR, Jang SC, Escobedo-Lucea C, Oliver-De La Cruz J, Siljander P, et al. Distinct prostate cancer-related mRNA cargo in extracellular vesicle subsets from prostate cell lines. BMC Cancer BMC Cancer. 2017;17:1–11.

Google Scholar 

Haraszti RA, Didiot MC, Sapp E, Leszyk J, Shaffer SA, Rockwell HE et al. High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources. J Extracell Vesicles. 2016;5.

Iraci N, Gaude E, Leonardi T, Costa ASH, Cossetti C, Peruzzotti-Jametti L, et al. Extracellular vesicles are independent metabolic units with asparaginase activity. Nat Chem Biol. 2017;13:951–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

He G, Peng X, Wei S, Yang S, Li X, Huang M et al. Exosomes in the hypoxic TME: from release, uptake and biofunctions to clinical applications. Mol Cancer [Internet]. BioMed Central; 2022;21:1–22. Available from: https://doi.org/10.1186/s12943-021-01440-5.

Puhka M, Takatalo M, Nordberg ME, Valkonen S, Nandania J, Aatonen M, et al. Metabolomic profiling of extracellular vesicles and alternative normalization methods reveal enriched metabolites and strategies to study prostate cancer-related changes. Theranostics. 2017;7:3824–41.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Palacios-Ferrer JL, García-Ortega MB, Gallardo-Gómez M, García M, Díaz C, Boulaiz H, et al. Metabolomic profile of cancer stem cell-derived exosomes from patients with malignant melanoma. Mol Oncol. 2021;15:407–28.

Article  CAS  PubMed  Google Scholar 

Chen Y, Zhu Q, Cheng L, Wang Y, Li M, Yang Q et al. Exosome detection via the ultrafast-isolation system: EXODUS. Nat Methods [Internet]. Springer US; 2021;18:212–8. Available from: https://doi.org/10.1038/s41592-020-01034-x.

Théry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7.

Alegre E, Zubiri L, Perez-Gracia JL, González-Cao M, Soria L, Martín-Algarra S et al. Circulating melanoma exosomes as diagnostic and prognosis biomarkers. Clin Chim Acta [Internet]. Elsevier B.V.; 2016;454:28–32. Available from: https://doi.org/10.1016/j.cca.2015.12.031.

Melo SA, Luecke LB, Kahlert C, Fernandez AF, Gammon ST, Kaye J, et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature. 2015;523:177–82.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lener T, Gimona M, Aigner L, Börger V, Buzas E, Camussi G et al. Applying extracellular vesicles based therapeutics in clinical trials - An ISEV position paper. J Extracell Vesicles. 2015;4.

Zhang J, Mu X, Xia Y, Martin FL, Hang W, Liu L, et al. Metabolomic analysis reveals a unique urinary pattern in normozoospermic infertile men. J Proteome Res. 2014;13:3088–99.

Article  CAS  PubMed  Google Scholar 

Tao JL, Chen YZ, Dai QG, Tian M, Wang SC, Shan JJ, et al. Urine metabolic profiles in paediatric asthma. Respirology. 2019;24:572–81.

Article  PubMed  Google Scholar 

Zhou J, Tang L, Wang JS. Assessment of the adverse impacts of aflatoxin B1 on gut-microbiota dependent metabolism in F344 rats. Chemosphere [Internet]. Elsevier Ltd; 2019;217:618–28. Available from: https://doi.org/10.1016/j.chemosphere.2018.11.044.

Li X, Xiang B, Shen T, Xiao C, Dai R, He F et al. Anti-neuroinflammatory effect of 3,4-dihydroxybenzaldehyde in ischemic stroke. Int Immunopharmacol. 2020;82.